110 related articles for article (PubMed ID: 16007009)
1. [Influence of combination of conventional therapy with local use of Supersorbicid on endotoxemic indices in patients with maxillofacial phlegmons].
Eshbadalov KhIu
Stomatologiia (Mosk); 2005; 84(3):27-8. PubMed ID: 16007009
[TBL] [Abstract][Full Text] [Related]
2. [Enzyme DNA-ase use in patients with maxillofacial abscesses and phlegmons].
Solov'ev MM; Tets VV; Bobrov AP; Artemenko KL; Moshkevich IR; Tets GV
Stomatologiia (Mosk); 2006; 85(6):40-5. PubMed ID: 17310949
[TBL] [Abstract][Full Text] [Related]
3. [Supersorbicid in comprehensive treatment of acute pyoinflammatory processes in maxillofacial region].
Eshbadalov KhIu
Stomatologiia (Mosk); 2005; 84(2):36-7. PubMed ID: 15798751
[TBL] [Abstract][Full Text] [Related]
4. [Dynamics of immune status in patients with phlegmons of the maxillofacial area during endolymphatic antibiotic therapy]].
Tereshenko AE; Agapov VS; Kuznetsov EA; Tsarev VN; Tarasenko SV
Stomatologiia (Mosk); 2000; 79(6):35-7. PubMed ID: 11186565
[TBL] [Abstract][Full Text] [Related]
5. [Clinical results of perftorane use in comprehensive treatment of patients with odontogenic phlegmons].
Durnovo EA; Furman IV
Stomatologiia (Mosk); 2007; 86(4):35-9. PubMed ID: 17828096
[TBL] [Abstract][Full Text] [Related]
6. [Free radicals process correction in comprehensive treatment of patients with odontogenic phlegmons of maxillofacial region].
Gaĭvoronskaia TV; Petrosian NE; Petrosian EA
Stomatologiia (Mosk); 2009; 88(2):47-9. PubMed ID: 19491784
[TBL] [Abstract][Full Text] [Related]
7. [Use of data of expected duration of treatment and estimation of severity level for selection of rational therapy in patients with acute inflammatory diseases of maxillofacial region].
Bogatov VV; Burova NM
Stomatologiia (Mosk); 2011; 90(1):49-51. PubMed ID: 21378723
[TBL] [Abstract][Full Text] [Related]
8. [Intensive therapy of odontogenic facial phlegmons].
Dunaevskiĭ VA; Mukovozov IN; Orlov VS
Vestn Khir Im I I Grek; 1976 Aug; 117(8):125-8. PubMed ID: 997103
[No Abstract] [Full Text] [Related]
9. [The clinical value of the middle-molecule metabolite index in assessing the severity of the intoxication syndrome in patients with maxillofacial phlegmons].
Grishkov SV; Temerkhanov FT; Fialko PN; Mel'nikova AV
Stomatologiia (Mosk); 1990; (4):33-5. PubMed ID: 2251693
[TBL] [Abstract][Full Text] [Related]
10. [The clinical value of determining erythrocyte sorption capacity and the levels of middle molecules and circulating immune complexes in assessing endotoxemia in patients with abscesses and phlegmons of the maxillofacial area].
Karshiev KhK
Stomatologiia (Mosk); 1998; 77(2):35-6. PubMed ID: 9584591
[TBL] [Abstract][Full Text] [Related]
11. [Results of perftorane local use in complex treatment of patients with odontogenic phlegmons of the face and neck].
Agapov VS; Piminova IA
Stomatologiia (Mosk); 2006; 85(5):32-5. PubMed ID: 17159841
[TBL] [Abstract][Full Text] [Related]
12. [The microflora in perimaxillary phlegmons and its sensitivity to antibiotics].
Kovaleva ZI
Stomatologiia (Mosk); 1970; 49(6):78-9. PubMed ID: 5278348
[No Abstract] [Full Text] [Related]
13. [Clinical immunological peculiarities of complicated course of odontogenic phlegmons of maxillofacial region].
Durnovo EA; Vysel'tseva IuV; Mishina NV; Khomutinnikova NE; Oleneva IuV; Katkova IuO; Ashkinazi VI
Stomatologiia (Mosk); 2010; 89(2):29-31. PubMed ID: 20517248
[TBL] [Abstract][Full Text] [Related]
14. [A comparative evaluation of various methods for determining the degree of endogenous intoxication in patients with phlegmons of the maxillofacial area].
Ganina SS; Perbokas F; Gabriélian NI; Belotserkovskaia OI
Stomatologiia (Mosk); 1990; 69(2):32-4. PubMed ID: 2371725
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of preparations with antioxidant action in the combined treatment of phlegmons of the maxillofacial area].
Ragimov ChR
Stomatologiia (Mosk); 1992; (3-6):35-7. PubMed ID: 1307152
[TBL] [Abstract][Full Text] [Related]
16. [Incidence, location, clinical course and therapy of abscesses and cellulitis in the maxillofacial region].
Kavlakov P; Atanasov D
Stomatologiia (Sofiia); 1977; 59(5):332-7. PubMed ID: 292237
[No Abstract] [Full Text] [Related]
17. [Intraarterial antibiotic therapy in comprehensive therapeutic and preventive measures against inflammatory processes in the maxillofacial area].
Shcherbatiuk DI; Topalo VM
Stomatologiia (Mosk); 1988; 67(4):33-5. PubMed ID: 3188095
[No Abstract] [Full Text] [Related]
18. [A comparative evaluation of the efficacy of endolymphatically administered antibiotics in the combined treatment of phlegmons of the maxillofacial area].
Tereshchenko AE; Kuznetsov EA
Stomatologiia (Mosk); 1996; Spec No():82-3. PubMed ID: 9281184
[No Abstract] [Full Text] [Related]
19. [Cytological evaluation of laser therapy influence upon skin reparation].
Pavlova NV; Petrova MB; Kharitonova EA; Shestakova VG
Stomatologiia (Mosk); 2010; 89(1):33-6. PubMed ID: 20436407
[TBL] [Abstract][Full Text] [Related]
20. [Latero-pharyngeal phlegmons and abscesses in adults. Reports of 6 cases and literature review].
Pino Rivero V; Trinidad Ruíz G; Pardo Romero G; Marcos García M; González Palomino A; Blasco Huelva A
An Otorrinolaringol Ibero Am; 2004; 31(2):105-13. PubMed ID: 15185606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
